Je. Galvin et al., Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein, P NAS US, 96(23), 1999, pp. 13450-13455
Citations number
41
Categorie Soggetti
Multidisciplinary
Journal title
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Pathogenic alpha-synuclein (alpha S) gene mutations occur in rare familial
Parkinson's disease (PD) kindreds, and wild-type alpha S is a major compone
nt of Lewy bodies (LBs) in sporadic PD, dementia with LBs (DLB), and the LB
variant of Alzheimer's disease, but beta-synuclein (beta s) and gamma-synu
clein (gamma S) have not yet been implicated in neurological disorders. Her
e we show that in PD and DLB, but not normal brains, antibodies to alpha S
and beta S reveal novel presynaptic axon terminal pathology in the hippocam
pal dentate, hilar, and CA2/3 regions, whereas antibodies to gamma S detect
previously unrecognized axonal spheroid-like lesions in the hippocampal de
ntate molecular layer. The aggregation of other synaptic proteins and synap
tic vesicle-like structures in the alpha S- and beta S-labeled hilar dystro
phic neurites suggests that synaptic dysfunction may result from these lesi
ons. Our findings broaden the concept of neurodegenerative "synucleinopathi
es'' by implicating beta S and gamma S, in addition to alpha S, in the onse
t/progression of PD and DLB.